Skip to main content
SpringerLink
Log in

Ungewisses Nutzen-Risiko-Verhältnis von Metformin

Metaanalyse zur Effizienz in der Diabetestherapie

Uncertain risk-benefit ratio of metformin

Meta-analysis on the efficacy in treatment of diabetes

  • Journal Club
  • Published:
Der Diabetologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of Intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854–865

    Article  Google Scholar 

  2. Saenz A, Fernandez-Esteban I, Mataix A et al (2005) Metformin monotherapy for type 2 diabetes mellitus. Cochrane Database Syst Rev:CD002966

    Google Scholar 

  3. Selvin E, Bolen S, Yeh HC et al (2008) Cardiovascular outcomes in trials of oral diabetes medications: a systematic review. Arch Intern Med 168:2070–2080

    Article  PubMed  Google Scholar 

  4. Bennett WL, Maruthur NM, Singh S et al (2011) Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med 154:602–613

    PubMed  Google Scholar 

  5. Lamanna C, Monami M, Marchionni N, Mannucci E (2011) Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomised clinical trials. Diabetes Obes Metab 13:221–228

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diabetologie, GK Havelhöhe, Kladoweer Damm 221, 14089, Berlin, Deutschland

    M. Jecht

Authors
  1. M. Jecht
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Jecht.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jecht, M. Ungewisses Nutzen-Risiko-Verhältnis von Metformin. Diabetologe 8, 579–580 (2012). https://doi.org/10.1007/s11428-012-0987-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11428-012-0987-x

Search

Navigation